Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Denali Therapeutics Inc (NASDAQ: DNLI) closed at $29.60 in the last session, up 0.17% from day before closing price of $29.55. In other words, the price has increased by $0.17 from its previous closing price. On the day, 0.89 million shares were traded. DNLI stock price reached its highest trading level at $31.405 during the session, while it also had its lowest trading level at $29.015.
Ratios:
We take a closer look at DNLI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.98 and its Current Ratio is at 9.98. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
On December 13, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $32.Citigroup initiated its Buy rating on December 13, 2023, with a $32 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 07 ’24 when ALEXANDER SCHUTH bought 15,558 shares for $29.55 per share.
SATO VICKI L sold 3,080 shares of DNLI for $83,376 on Nov 01 ’24. The Director now owns 112,076 shares after completing the transaction at $27.07 per share. On Oct 18 ’24, another insider, Watts Ryan J., who serves as the President and CEO of the company, sold 40,000 shares for $27.69 each. As a result, the insider received 1,107,600 and left with 235,807 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNLI now has a Market Capitalization of 4260091136 and an Enterprise Value of 4231884800.
Stock Price History:
Over the past 52 weeks, DNLI has reached a high of $32.13, while it has fallen to a 52-week low of $14.56. The 50-Day Moving Average of the stock is 6.98%, while the 200-Day Moving Average is calculated to be 34.27%.
Shares Statistics:
According to the various share statistics, DNLI traded on average about 832.90K shares per day over the past 3-months and 765500 shares per day over the past 10 days. A total of 138.39M shares are outstanding, with a floating share count of 119.11M. Insiders hold about 16.80% of the company’s shares, while institutions hold 83.92% stake in the company. Shares short for DNLI as of 1728950400 were 7733458 with a Short Ratio of 9.28, compared to 1726185600 on 9397380. Therefore, it implies a Short% of Shares Outstanding of 7733458 and a Short% of Float of 6.329999999999999.
